Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-Nh2 (4-9 Disulfide)

Hepatorenal Syndrome

Noorik Biopharmaceuticals AGprotein_peptidePhase 4 / ApprovedActive

84/ 100

Provisional rating · Methodology v0.2

Rating breakdown

4 Active assets in the Hepatorenal Syndrome cohort.

Asset / Sponsor	Phase	Rating
NORMAL HUMAN SERUM ALBUMIN Massachusetts General Hospital	Phase 4	BBB
Norfloxacin Hospital Clinic of Barcelona	Phase 4	BB
L-CYSTEINAMIDE, D-PHENYLALANYL-L-CYSTEINYL-L-PHENYLALANYL-D-TRYPTOPHYL-L-LYSYL-L-THREONYL-N-(2-HYDROXY-1-(HYDROXYMETHYL)PROPYL)-, CYCLIC (2->7)-DISULFIDE, (R-(R,R))- University of California, Los Angeles	Phase 2/3	BB
Midodrine University of California, Los Angeles	Phase 2/3	BB
[Phe^2,Ile^3,Dab(PhAc-D-Tyr(Me)-Phe-Gln-Asn-Ala-Pro-Arg-iGln-Lys(Ac)-Epsilon-Lys)^8]vasopressin Ocelot Bio, Inc	Phase 2	B